H.C. Wainwright Reiterates Buy Rating on Actuate Therapeutics (ACTU)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/21/2026

1. BA
2. RTX
3. SPY
4. USO
5. AMC
6. NVDA
7. XFLT
8. GE
9. TRV
10. PSNL

Go back to H.C. Wainwright Reiterates Buy Rating on Actuate Therapeutics (ACTU)
ACTUATE (NASDAQ: ACTU) Delayed: 1.40 -0.04 (2.78%)
Previous Close $1.44    52 Week High $6.07 
Open $1.53    52 Week Low $3.89 
Day High $1.53    P/E 9.33 
Day Low $1.37    EPS $0.15 
Volume 139,869